NEW YORK, Jan. 19 (GenomeWeb News) - Tm Bioscience expects to raise CA$7.5 million ($6.13 million) through a private placement of 3.5 million common shares with a syndicate of underwriters, the company said today.
Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.
In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.
